Biogen secures $1.5B loan to fund Reata buyout, with three-year repayment schedule baked in
Biogen has lined up a $1.5 billion term loan to fund its $7.3 billion acquisition of Reata Pharmaceuticals.
The company had made clear its intentions …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
